✦ LIBER ✦

A Hierarchical Bayesian Design for Phase I Trials of Novel Combinations of Cancer Therapeutic Agents

✍ Scribed by Thomas M. Braun; Shufang Wang

Book ID: 109224303
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 172 KB
Volume: 66
Category: Article
ISSN: 0006-341X
DOI: 10.1111/j.1541-0420.2009.01363.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I trial of fixed dose-rate gemcita

Phase I trial of fixed dose-rate gemcitabine in combination with carboplatin in chemonaive advanced non-small-cell lung cancer: a Cancer Therapeutics Research Group study

✍ Ross A. Soo; Hong L. Lim; Ling Z. Wang; How S. Lee; Michael J. Millward; Lay T. 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 198 KB

Phase 2 trial of a novel capecitabine do

Phase 2 trial of a novel capecitabine dosing schedule in combination with bevacizumab for patients with metastatic breast cancer

✍ Devika Gajria; Kim Feigin; Lee K. Tan; Sujata Patil; Stephanie Geneus; Maria The 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB 👁 1 views

A phase I trial of 3-aminopyridine-2-car

A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

✍ Yun Yen; Kim Margolin; James Doroshow; Mayer Fishman; Bonny Johnson; Caroline Cl 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 233 KB

Soluble E-selectin in cancer patients as

Soluble E-selectin in cancer patients as a marker of the therapeutic efficacy of CM101, a tumor-inhibiting anti-neovascularization agent, evaluated in phase I clinical trial

✍ Barbara D. Wamil; Gary B. Thurman; Hakan W. Sundell; Russel F. DeVore; Gail Wake 📂 Article 📅 1997 🏛 Springer-Verlag 🌐 English ⚖ 703 KB

Phase II trial of a novel capecitabine d

Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancer

✍ Devika Gajria; Joseph Gonzalez; Kimberly Feigin; Sujata Patil; Carol Chen; Maria 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 219 KB

Non-pegylated liposomal doxorubicin comb

Non-pegylated liposomal doxorubicin combined with gemcitabine as first-line treatment for metastatic or locally advanced breast cancer. Final results of a phase I/II trial

✍ S. Del Barco; R. Colomer; L. Calvo; I. Tusquets; E. Adrover; P. Sánchez; J. Rifà 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 220 KB